Achilles Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Achilles Therapeutics plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $4.17M, a 50.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.17M -$4.21M -50.3% Jun 30, 2024 6-K 2024-08-14
Q4 2023 $4.37M -$3.71M -45.9% Dec 31, 2023 6-K 2024-08-14
Q2 2023 $8.37M Jun 30, 2023 6-K 2023-08-04
Q4 2022 $8.08M -$2.97M -26.9% Dec 31, 2022 20-F 2024-04-04
Q4 2021 $11M -$3.69M -25% Dec 31, 2021 20-F 2023-03-07
Q4 2020 $14.7M Dec 31, 2020 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.